- Home
- FVRR vs PCRX Comparison
FVRR vs PCRX Comparison
Compare FVRR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- PCRX
- Stock Information
- Founded
- FVRR 2010
- PCRX 2006
- Country
- FVRR Israel
- PCRX United States
- Employees
- FVRR N/A
- PCRX N/A
- Industry
- FVRR Business Services
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- PCRX Health Care
- Exchange
- FVRR Nasdaq
- PCRX Nasdaq
- Market Cap
- FVRR 1.1B
- PCRX 1.2B
- IPO Year
- FVRR 2019
- PCRX 2011
- Fundamental
- Price
- FVRR $29.04
- PCRX $24.10
- Analyst Decision
- FVRR Buy
- PCRX Buy
- Analyst Count
- FVRR 12
- PCRX 9
- Target Price
- FVRR $35.00
- PCRX $29.89
- AVG Volume (30 Days)
- FVRR 457.9K
- PCRX 546.7K
- Earning Date
- FVRR 07-30-2025
- PCRX 07-29-2025
- Dividend Yield
- FVRR N/A
- PCRX N/A
- EPS Growth
- FVRR 127.71
- PCRX N/A
- EPS
- FVRR 0.49
- PCRX N/A
- Revenue
- FVRR $405,141,000.00
- PCRX $702,772,000.00
- Revenue This Year
- FVRR $13.12
- PCRX $7.54
- Revenue Next Year
- FVRR $8.65
- PCRX $10.78
- P/E Ratio
- FVRR $60.92
- PCRX N/A
- Revenue Growth
- FVRR 10.41
- PCRX 3.08
- 52 Week Low
- FVRR $20.78
- PCRX $11.16
- 52 Week High
- FVRR $36.11
- PCRX $29.61
- Technical
- Relative Strength Index (RSI)
- FVRR 39.40
- PCRX 36.99
- Support Level
- FVRR $28.96
- PCRX $23.99
- Resistance Level
- FVRR $30.18
- PCRX $24.90
- Average True Range (ATR)
- FVRR 1.06
- PCRX 0.88
- MACD
- FVRR -0.60
- PCRX -0.21
- Stochastic Oscillator
- FVRR 9.44
- PCRX 11.61
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.